{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:26:57Z","timestamp":1768292817326,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1124\/jpet.103.061192","type":"journal-article","created":{"date-parts":[[2004,3,26]],"date-time":"2004-03-26T18:07:46Z","timestamp":1080324466000},"page":"137-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Role of \u03b1-Adrenergic Receptors in the Effect of the \u03b2-Adrenergic Receptor Ligands, CGP 12177, Bupranolol, and SR 59230A, on the Contraction of Rat Intrapulmonary Artery"],"prefix":"10.1016","volume":"309","author":[{"given":"V\u00e9ronique","family":"Leblais","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Pourageaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Dolores","family":"Ivorra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Guibert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Marthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.103.061192_bib1","doi-asserted-by":"crossref","unstructured":"Berlan M, Galitzky J, Bousquet-Melou A, Lafontan M, and Montastruc JL (1994) Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog. J Pharmacol Exp Ther 268: 1444-1451.","DOI":"10.1016\/S0022-3565(25)38598-8"},{"key":"10.1124\/jpet.103.061192_bib2","doi-asserted-by":"crossref","unstructured":"Bhattacharya B and Roberts RE (2003) Enhancement of alpha(2)-adrenoceptormediated vasoconstriction by the thromboxane-mimetic U46619 in the porcine isolated ear artery: role of the ERK-MAP kinase signal transduction cascade. Br J Pharmacol 139: 156-162.","DOI":"10.1038\/sj.bjp.0705208"},{"key":"10.1124\/jpet.103.061192_bib3","doi-asserted-by":"crossref","unstructured":"Blin N, Camoin L, Maigret B, and Strosberg AD (1993) Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor. Mol Pharmacol 44: 1094-1104.","DOI":"10.1016\/S0026-895X(25)13306-3"},{"key":"10.1124\/jpet.103.061192_bib4","doi-asserted-by":"crossref","unstructured":"Boer C, van der Linden PJ, Scheffer GJ, Westerhof N, de Lange JJ, and Sipkema P (2002) RhoA\/Rho kinase and nitric oxide modulate the agonist-induced pulmonary artery diameter response time. Am J Physiol Heart Circ Physiol 282: H990-H998.","DOI":"10.1152\/ajpheart.00093.2001"},{"key":"10.1124\/jpet.103.061192_bib5","doi-asserted-by":"crossref","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.","DOI":"10.1006\/abio.1976.9999"},{"key":"10.1124\/jpet.103.061192_bib6","doi-asserted-by":"crossref","unstructured":"Brahmadevara N, Shaw AM, and MacDonald A (2003) Evidence against beta 3-adrenoceptors or low affinity state of beta 1-adrenoceptors mediating relaxation in rat isolated aorta. Br J Pharmacol 138: 99-106.","DOI":"10.1038\/sj.bjp.0705017"},{"key":"10.1124\/jpet.103.061192_bib7","doi-asserted-by":"crossref","unstructured":"Brawley L, Shaw AM, and MacDonald A (2000) Beta 1-, beta 2- and atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta. Br J Pharmacol 129: 637-644.","DOI":"10.1038\/sj.bjp.0703091"},{"key":"10.1124\/jpet.103.061192_bib8","doi-asserted-by":"crossref","unstructured":"Cheng Y and Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108.","DOI":"10.1016\/0006-2952(73)90196-2"},{"key":"10.1124\/jpet.103.061192_bib9","doi-asserted-by":"crossref","unstructured":"Choppin A and O\u2019Connor SE (1995) Presence of vasoconstrictor 5HT1-like receptors revealed by precontraction of rabbit isolated mesenteric artery. Br J Pharmacol 114: 309-314.","DOI":"10.1111\/j.1476-5381.1995.tb13228.x"},{"key":"10.1124\/jpet.103.061192_bib10","doi-asserted-by":"crossref","unstructured":"Dumas M, Dumas JP, Bardou M, Rochette L, Advenier C, and Giudicelli JF (1998) Influence of beta-adrenoceptor agonists on the pulmonary circulation. Effects of a beta3-adrenoceptor antagonist, SR 59230A. Eur J Pharmacol 348: 223-228.","DOI":"10.1016\/S0014-2999(98)00146-0"},{"key":"10.1124\/jpet.103.061192_bib11","doi-asserted-by":"crossref","unstructured":"Fabi F, Argiolas L, Ruvolo G, and del Basso P (1998) Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane. Br J Pharmacol 124: 101-110.","DOI":"10.1038\/sj.bjp.0701808"},{"key":"10.1124\/jpet.103.061192_bib12","doi-asserted-by":"crossref","unstructured":"Feve B, Emorine LJ, Lasnier F, Blin N, Baude B, Nahmias C, Strosberg AD, and Pairault J (1991) Atypical beta-adrenergic receptor in 3T3\u2013F442A adipocytes. Pharmacological and molecular relationship with the human beta 3-adrenergic receptor. J Biol Chem 266: 20329-20336.","DOI":"10.1016\/S0021-9258(18)54927-9"},{"key":"10.1124\/jpet.103.061192_bib13","doi-asserted-by":"crossref","unstructured":"Granneman JG (2001) The putative beta4-adrenergic receptor is a novel state of the beta1-adrenergic receptor. Am J Physiol Endocrinol Metab 280: E199-E202.","DOI":"10.1152\/ajpendo.2001.280.2.E199"},{"key":"10.1124\/jpet.103.061192_bib14","unstructured":"Granneman JG, Lahners KN, and Chaudhry A (1991) Molecular cloning and expression of the rat beta 3-adrenergic receptor. Mol Pharmacol 40: 895-899."},{"key":"10.1124\/jpet.103.061192_bib15","doi-asserted-by":"crossref","unstructured":"Henrion D and Laher I (1994) Insulin potentiates norepinephrine-induced vascular tone by activation of protein kinase C and tyrosine kinase. Can J Physiol Pharmacol 72: 849-854.","DOI":"10.1139\/y94-120"},{"key":"10.1124\/jpet.103.061192_bib16","doi-asserted-by":"crossref","unstructured":"Horinouchi T and Koike K (2001) Agonistic activity of SR59230A at atypical beta-adrenoceptors in guinea pig gastric fundus and duodenum. Eur J Pharmacol 416: 165-168.","DOI":"10.1016\/S0014-2999(01)00854-8"},{"key":"10.1124\/jpet.103.061192_bib17","doi-asserted-by":"crossref","unstructured":"Kaumann AJ, Preitner F, Sarsero D, Molenaar P, Revelli JP, and Giacobino JP (1998) (-)-CGP 12177 causes cardiostimulation and binds to cardiac putative beta 4-adrenoceptors in both wild-type and beta 3-adrenoceptor knockout mice. Mol Pharmacol 53: 670-675.","DOI":"10.1124\/mol.53.4.670"},{"key":"10.1124\/jpet.103.061192_bib18","unstructured":"Kenakin T (1993) Pharmacologic Analysis of Drug-Receptor Interaction. Raven Press, Ltd., New York."},{"key":"10.1124\/jpet.103.061192_bib19","doi-asserted-by":"crossref","unstructured":"Konkar AA, Zhai Y, and Granneman JG (2000a) Beta1-adrenergic receptors mediate beta3-adrenergic-independent effects of CGP 12177 in brown adipose tissue. Mol Pharmacol 57: 252-258.","DOI":"10.1016\/S0026-895X(24)23196-5"},{"key":"10.1124\/jpet.103.061192_bib20","doi-asserted-by":"crossref","unstructured":"Konkar AA, Zhu Z, and Granneman JG (2000b) Aryloxypropanolamine and catecholamine ligand interactions with the beta(1)-adrenergic receptor: evidence for interaction with distinct conformations of beta(1)-adrenergic receptors. J Pharmacol Exp Ther 294: 923-932.","DOI":"10.1016\/S0022-3565(24)39154-2"},{"key":"10.1124\/jpet.103.061192_bib21","doi-asserted-by":"crossref","unstructured":"Kozlowska H, Szymska U, Schlicker E, and Malinowska B (2003) Atypical {beta}-adrenoceptors, different from {beta}3-adrenoceptors and probably from the low-affinity state of {beta}1-adrenoceptors, relax the rat isolated mesenteric artery. Br J Pharmacol 140: 3-12.","DOI":"10.1038\/sj.bjp.0705421"},{"key":"10.1124\/jpet.103.061192_bib22","doi-asserted-by":"crossref","unstructured":"Leach RM, Twort CH, Cameron IR, and Ward JP (1992) A comparison of the pharmacological and mechanical properties in vitro of large and small pulmonary arteries of the rat. Clin Sci (Lond) 82: 55-62.","DOI":"10.1042\/cs0820055"},{"key":"10.1124\/jpet.103.061192_bib23","unstructured":"Leblais V, Pourageaud F, Marthan R, and Muller B (2003) Evidence for contribution of alpha-adrenoceptors in the effects of CGP 12177 in rat pulmonary arteries (Abstract). Fundam Clin Pharmacol 17: 227-269."},{"key":"10.1124\/jpet.103.061192_bib24","doi-asserted-by":"crossref","unstructured":"Lowe MD, Lynham JA, Grace AA, and Kaumann AJ (2002) Comparison of the affinity of beta-blockers for two states of the beta 1-adrenoceptor in ferret ventricular myocardium. Br J Pharmacol 135: 451-461.","DOI":"10.1038\/sj.bjp.0704450"},{"key":"10.1124\/jpet.103.061192_bib25","doi-asserted-by":"crossref","unstructured":"MacDonald A, McLean M, MacAulay L, and Shaw AM (1999) Effects of propranolol and l-NAME on beta-adrenoceptor-mediated relaxation in rat carotid artery. J Auton Pharmacol 19: 145-149.","DOI":"10.1046\/j.1365-2680.1999.00128.x"},{"key":"10.1124\/jpet.103.061192_bib26","doi-asserted-by":"crossref","unstructured":"Madrero Y, Elorriaga M, Martinez S, Noguera MA, Cassels BK, D\u2019Ocon P, and Ivorra MD (1996) A possible structural determinant of selectivity of boldine and derivatives for the alpha 1A-adrenoceptor subtype. Br J Pharmacol 119: 1563-1568.","DOI":"10.1111\/j.1476-5381.1996.tb16073.x"},{"key":"10.1124\/jpet.103.061192_bib27","doi-asserted-by":"crossref","unstructured":"Molenaar P (2003) The\u2019state\u2019 of beta-adrenoceptors. Br J Pharmacol 140: 1-2.","DOI":"10.1038\/sj.bjp.0705420"},{"key":"10.1124\/jpet.103.061192_bib28","doi-asserted-by":"crossref","unstructured":"Movahedi H and Purdy RE (1997) Pharmacological characterization of the \u201csilent\u201d 5-hydroxytryptamine1B-like receptors of rabbit ear artery. J Pharmacol Exp Ther 283: 653-660.","DOI":"10.1016\/S0022-3565(24)37057-0"},{"key":"10.1124\/jpet.103.061192_bib29","doi-asserted-by":"crossref","unstructured":"Nanoff C, Freissmuth M, and Schutz W (1987) The role of a low beta 1-adrenoceptor selectivity of [3H]CGP-12177 for resolving subtype-selectivity of competitive ligands. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 336: 519-525.","DOI":"10.1007\/BF00169308"},{"key":"10.1124\/jpet.103.061192_bib30","doi-asserted-by":"crossref","unstructured":"Nisoli E, Tonello C, Landi M, and Carruba MO (1996) Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes. Mol Pharmacol 49: 7-14.","DOI":"10.1016\/S0026-895X(25)08695-X"},{"key":"10.1124\/jpet.103.061192_bib31","doi-asserted-by":"crossref","unstructured":"Oriowo MA (1994) Atypical beta-adrenoceptors in the rat isolated common carotid artery. Br J Pharmacol 113: 699-702.","DOI":"10.1111\/j.1476-5381.1994.tb17049.x"},{"key":"10.1124\/jpet.103.061192_bib32","doi-asserted-by":"crossref","unstructured":"Preitner F, Muzzin P, Revelli JP, Seydoux J, Galitzky J, Berlan M, Lafontan M, and Giacobino JP (1998) Metabolic response to various beta-adrenoceptor agonists in beta3-adrenoceptor knockout mice: evidence for a new beta-adrenergic receptor in brown adipose tissue. Br J Pharmacol 124: 1684-1688.","DOI":"10.1038\/sj.bjp.0702007"},{"key":"10.1124\/jpet.103.061192_bib33","doi-asserted-by":"crossref","unstructured":"Rautureau Y, Toumaniantz G, Serpillon S, Jourdon P, Trochu JN, and Gauthier C (2002) Beta 3-adrenoceptor in rat aorta: molecular and biochemical characterization and signalling pathway. Br J Pharmacol 137: 153-161.","DOI":"10.1038\/sj.bjp.0704867"},{"key":"10.1124\/jpet.103.061192_bib34","doi-asserted-by":"crossref","unstructured":"Shafiei M and Mahmoudian M (1999) Atypical beta-adrenoceptors of rat thoracic aorta. Gen Pharmacol 32: 557-562.","DOI":"10.1016\/S0306-3623(98)00283-3"},{"key":"10.1124\/jpet.103.061192_bib35","doi-asserted-by":"crossref","unstructured":"Shen YT, Cervoni P, Claus T, and Vatner SF (1996) Differences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs. J Pharmacol Exp Ther 278: 1435-1443.","DOI":"10.1016\/S0022-3565(25)20798-4"},{"key":"10.1124\/jpet.103.061192_bib36","doi-asserted-by":"crossref","unstructured":"Staehelin M, Simons P, Jaeggi K, and Wigger N (1983) CGP-12177. A hydrophilic beta-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells. J Biol Chem 258: 3496-3502.","DOI":"10.1016\/S0021-9258(18)32689-9"},{"key":"10.1124\/jpet.103.061192_bib37","doi-asserted-by":"crossref","unstructured":"Strange JW, Wharton J, Phillips PG, and Wilkins MR (2002) Recent insights into the pathogenesis and therapeutics of pulmonary hypertension. Clin Sci (Lond) 102: 253-268.","DOI":"10.1042\/cs1020253"},{"key":"10.1124\/jpet.103.061192_bib38","doi-asserted-by":"crossref","unstructured":"Strosberg AD (1997) Structure and function of the beta 3-adrenergic receptor. Annu Rev Pharmacol Toxicol 37: 421-450.","DOI":"10.1146\/annurev.pharmtox.37.1.421"},{"key":"10.1124\/jpet.103.061192_bib39","doi-asserted-by":"crossref","unstructured":"Tamaoki J, Tagaya E, Isono K, and Nagai A (1998) Atypical adrenoceptor-mediated relaxation of canine pulmonary artery through a cAMP-dependent pathway. Biochem Biophys Res Commun 248: 722-727.","DOI":"10.1006\/bbrc.1998.9047"},{"key":"10.1124\/jpet.103.061192_bib40","doi-asserted-by":"crossref","unstructured":"Trochu JN, Leblais V, Rautureau Y, Beverelli F, Le Marec H, Berdeaux A, and Gauthier C (1999) Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta. Br J Pharmacol 128: 69-76.","DOI":"10.1038\/sj.bjp.0702797"},{"key":"10.1124\/jpet.103.061192_bib41","doi-asserted-by":"crossref","unstructured":"Yan M, Sun J, Bird PI, Liu DL, Grigg M, and Lim YL (2001) Alpha1A- and alpha1B-adrenoceptors are the major subtypes in human saphenous vein. Life Sci 68: 1191-1198.","DOI":"10.1016\/S0024-3205(00)01027-4"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524312595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524312595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.103.061192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:49:33Z","timestamp":1739998173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524312595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0022356524312595"],"URL":"https:\/\/doi.org\/10.1124\/jpet.103.061192","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of \u03b1-Adrenergic Receptors in the Effect of the \u03b2-Adrenergic Receptor Ligands, CGP 12177, Bupranolol, and SR 59230A, on the Contraction of Rat Intrapulmonary Artery","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.103.061192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}